Acute and Subacute Toxicity Assessment of Andrographolide-2-hydroxypropyl-β-cyclodextrin Complex via Oral and Inhalation Route of Administration in Sprague-Dawley Rats
Objective. Acute and subacute toxicity analysis of AND-2-HyP-β-CYD complex was conducted in Sprague-Dawley (SD) rats following oral and inhalation routes of administration. Methods and Results. Single dose acute toxicity was carried out at 2000 mg/kg of AND-2-HyP-β-CYD complex, while the doses of 20...
Saved in:
| Main Authors: | , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2022-01-01
|
| Series: | The Scientific World Journal |
| Online Access: | http://dx.doi.org/10.1155/2022/6224107 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1850159880762032128 |
|---|---|
| author | Shashi Chandrama Singh Muskan Choudhary Atul Mourya Dharmendra Kumar Khatri Pankaj Kumar Singh Jitender Madan Harshpal Singh |
| author_facet | Shashi Chandrama Singh Muskan Choudhary Atul Mourya Dharmendra Kumar Khatri Pankaj Kumar Singh Jitender Madan Harshpal Singh |
| author_sort | Shashi Chandrama Singh |
| collection | DOAJ |
| description | Objective. Acute and subacute toxicity analysis of AND-2-HyP-β-CYD complex was conducted in Sprague-Dawley (SD) rats following oral and inhalation routes of administration. Methods and Results. Single dose acute toxicity was carried out at 2000 mg/kg of AND-2-HyP-β-CYD complex, while the doses of 200, 400, and 666 mg/kg were administered, over a period of 28 days under repeated dose oral toxicity study. Hence, LD50 (lethal dose) was found to be >2000 mg/kg in addition to NOAEL (no observed adverse effect level) of 666 mg/kg. Correspondingly, single dose acute inhalation toxicity of AND-2-HyP-β-CYD complex was carried out at 5 mg/L/4 h/day and subacute inhalation toxicity at 0.5, 1, and 1.66 mg/L/4 h/day over a period of 28 days. The NOAEL and LOAEL (lowest observed adverse effect level) were estimated to be 0.5 mg/L/4 h/day and 1 mg/L/4 h/day, respectively. Conclusion. The findings of the present study would further be useful in assessing and utilizing the medicinal and therapeutic benefits of AND-2-HyP-β-CYD complex. |
| format | Article |
| id | doaj-art-b97a92892e754a46a6e5e0a67f28b4e5 |
| institution | OA Journals |
| issn | 1537-744X |
| language | English |
| publishDate | 2022-01-01 |
| publisher | Wiley |
| record_format | Article |
| series | The Scientific World Journal |
| spelling | doaj-art-b97a92892e754a46a6e5e0a67f28b4e52025-08-20T02:23:19ZengWileyThe Scientific World Journal1537-744X2022-01-01202210.1155/2022/6224107Acute and Subacute Toxicity Assessment of Andrographolide-2-hydroxypropyl-β-cyclodextrin Complex via Oral and Inhalation Route of Administration in Sprague-Dawley RatsShashi Chandrama Singh0Muskan Choudhary1Atul Mourya2Dharmendra Kumar Khatri3Pankaj Kumar Singh4Jitender Madan5Harshpal Singh6Research and Development CentreResearch and Development CentreDepartment of PharmaceuticsDepartment of Biological SciencesDepartment of PharmaceuticsDepartment of PharmaceuticsResearch and Development CentreObjective. Acute and subacute toxicity analysis of AND-2-HyP-β-CYD complex was conducted in Sprague-Dawley (SD) rats following oral and inhalation routes of administration. Methods and Results. Single dose acute toxicity was carried out at 2000 mg/kg of AND-2-HyP-β-CYD complex, while the doses of 200, 400, and 666 mg/kg were administered, over a period of 28 days under repeated dose oral toxicity study. Hence, LD50 (lethal dose) was found to be >2000 mg/kg in addition to NOAEL (no observed adverse effect level) of 666 mg/kg. Correspondingly, single dose acute inhalation toxicity of AND-2-HyP-β-CYD complex was carried out at 5 mg/L/4 h/day and subacute inhalation toxicity at 0.5, 1, and 1.66 mg/L/4 h/day over a period of 28 days. The NOAEL and LOAEL (lowest observed adverse effect level) were estimated to be 0.5 mg/L/4 h/day and 1 mg/L/4 h/day, respectively. Conclusion. The findings of the present study would further be useful in assessing and utilizing the medicinal and therapeutic benefits of AND-2-HyP-β-CYD complex.http://dx.doi.org/10.1155/2022/6224107 |
| spellingShingle | Shashi Chandrama Singh Muskan Choudhary Atul Mourya Dharmendra Kumar Khatri Pankaj Kumar Singh Jitender Madan Harshpal Singh Acute and Subacute Toxicity Assessment of Andrographolide-2-hydroxypropyl-β-cyclodextrin Complex via Oral and Inhalation Route of Administration in Sprague-Dawley Rats The Scientific World Journal |
| title | Acute and Subacute Toxicity Assessment of Andrographolide-2-hydroxypropyl-β-cyclodextrin Complex via Oral and Inhalation Route of Administration in Sprague-Dawley Rats |
| title_full | Acute and Subacute Toxicity Assessment of Andrographolide-2-hydroxypropyl-β-cyclodextrin Complex via Oral and Inhalation Route of Administration in Sprague-Dawley Rats |
| title_fullStr | Acute and Subacute Toxicity Assessment of Andrographolide-2-hydroxypropyl-β-cyclodextrin Complex via Oral and Inhalation Route of Administration in Sprague-Dawley Rats |
| title_full_unstemmed | Acute and Subacute Toxicity Assessment of Andrographolide-2-hydroxypropyl-β-cyclodextrin Complex via Oral and Inhalation Route of Administration in Sprague-Dawley Rats |
| title_short | Acute and Subacute Toxicity Assessment of Andrographolide-2-hydroxypropyl-β-cyclodextrin Complex via Oral and Inhalation Route of Administration in Sprague-Dawley Rats |
| title_sort | acute and subacute toxicity assessment of andrographolide 2 hydroxypropyl β cyclodextrin complex via oral and inhalation route of administration in sprague dawley rats |
| url | http://dx.doi.org/10.1155/2022/6224107 |
| work_keys_str_mv | AT shashichandramasingh acuteandsubacutetoxicityassessmentofandrographolide2hydroxypropylbcyclodextrincomplexviaoralandinhalationrouteofadministrationinspraguedawleyrats AT muskanchoudhary acuteandsubacutetoxicityassessmentofandrographolide2hydroxypropylbcyclodextrincomplexviaoralandinhalationrouteofadministrationinspraguedawleyrats AT atulmourya acuteandsubacutetoxicityassessmentofandrographolide2hydroxypropylbcyclodextrincomplexviaoralandinhalationrouteofadministrationinspraguedawleyrats AT dharmendrakumarkhatri acuteandsubacutetoxicityassessmentofandrographolide2hydroxypropylbcyclodextrincomplexviaoralandinhalationrouteofadministrationinspraguedawleyrats AT pankajkumarsingh acuteandsubacutetoxicityassessmentofandrographolide2hydroxypropylbcyclodextrincomplexviaoralandinhalationrouteofadministrationinspraguedawleyrats AT jitendermadan acuteandsubacutetoxicityassessmentofandrographolide2hydroxypropylbcyclodextrincomplexviaoralandinhalationrouteofadministrationinspraguedawleyrats AT harshpalsingh acuteandsubacutetoxicityassessmentofandrographolide2hydroxypropylbcyclodextrincomplexviaoralandinhalationrouteofadministrationinspraguedawleyrats |